Ganyan-1 in Dry Eye
NCT06818487 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219
Last updated 2025-06-25
Summary
Ganyan -1 for the patients with dry eye
Conditions
- Dry Eye
- TCM
Interventions
- DRUG
-
Ganyan1
During the treatment period, participants will receive the following Chinese herbal granules, including Chrysanthemum, Dendrobium, Salvia miltiorrhiza, Gypsum Fibrosum, and Goji berries, administered twice daily at a dose of 10 g per time for a duration of 4 weeks.
- DRUG
-
Sodium Hyaluronate
Participants received 0.1% sodium hyaluronate eye drop
- DRUG
-
1/2Ganyan1
During the treatment period, participants will receive the following Chinese herbal granules, including Chrysanthemum, Dendrobium, Salvia miltiorrhiza, Gypsum Fibrosum, and Goji berries, administered twice daily at a dose of 5 g per time for a duration of 4 weeks.
- DRUG
-
Participants will receive the following placebo Chinese herbal granules, administered twice daily at a dose of 10 g per time for a duration of 4 weeks.
Sponsors & Collaborators
-
Beijing Tongren Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2027-01-01
- Completion
- 2027-02-01
More Related Trials
-
The Beijing Adult Dry Eye Cohort Study
NCT06621446 ·Status: ACTIVE_NOT_RECRUITING
-
Mask-associated Dry Eye Symptoms in China
NCT04744805 ·Status: UNKNOWN
-
Phase III Clinical Study of Lifitegrast Ophthalmic Solution for the Treatment of Dry Eye Disease
NCT06879782 ·Status: RECRUITING ·Phase: PHASE3
-
A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye
NCT04092907 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483 ·Status: COMPLETED ·Phase: PHASE2
-
Study of OT202 in Treating Moderate to Severe Dry Eye
NCT06435182 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1/2a Safety and Efficacy of ALY688 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT04201574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease
NCT01562795 ·Status: COMPLETED ·Phase: NA
-
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1
NCT02597803 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
NCT06717152 ·Status: COMPLETED ·Phase: PHASE3
-
Study of 5% VVN001 Ophthalmic Solution in Dry Eye Disease
NCT06360133 ·Status: RECRUITING ·Phase: PHASE3
-
Bilberry-containing Capsules for Dry Eye Mitigation
NCT05737108 ·Status: COMPLETED ·Phase: NA
-
A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye Syndromes
NCT01692145 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating HBM9036 Efficacy and Safety on Moderate to Severe Dry Eye
NCT04633213 ·Status: COMPLETED ·Phase: PHASE3
-
Correlation of Noninvasive Tear Film Function and the Optical Quality in Mild and Moderate Dry Eye
NCT03815539 ·Status: UNKNOWN ·Phase: NA
-
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
NCT01427816 ·Status: COMPLETED ·Phase: PHASE2
-
Managing Dry Eye in Patients Using Glaucoma Drops
NCT06158984 ·Status: COMPLETED ·Phase: NA
-
Non Interventional Study to Evaluate the Efficacy and Tolerability of Ectoin Containing Ophthalmic Solution
NCT01684852 ·Status: COMPLETED
-
A Randomized Study of Smile Exercise for Dry Eye
NCT04421300 ·Status: COMPLETED ·Phase: NA
-
The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients
NCT01250171 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry Eye
NCT01843894 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Wireless Micropump in Dry Eye Patients
NCT04667819 ·Status: UNKNOWN ·Phase: NA
-
A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
NCT03846453 ·Status: COMPLETED ·Phase: PHASE3
-
Walnut Shell Glasses Moxibustion for Dry Eye Syndrome
NCT03116776 ·Status: UNKNOWN ·Phase: NA